lobbying_activities: 2025979
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025979 | 8b573a16-b7d6-49b4-9a6c-3e670b950143 | Q3 | THE PAUL LAXALT GROUP | 22325 | THE ROGOSIN INSTITUTE | 2017 | third_quarter | MED | Monitor issues concerning improvements in medical research and treatment of kidney disease. Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 - S. 870 | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-10-16T17:04:30.987000-04:00 |